Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Detection of endometrial and ovarian cancers through DNA screening of Pap smears

Jan. 16, 2013

Argos Therapeutics enrolls first patients in phase III ADAPT study

Jan. 16, 2013

Vertex Pharmaceuticals synthesizes new protein kinase inhibitors

Jan. 16, 2013

Bayer Healthcare patents novel Mnk1 inhibitors for cancer

Jan. 15, 2013

VG Life Sciences expands phase I ovarian cancer trial into all solid tumors

Jan. 15, 2013

Research uncovers benefit of combined PI3K/mTOR and JAK2 inhibition

Jan. 15, 2013

European Commission approves use of Zytiga earlier in the treatment cycle

Jan. 14, 2013

Topline data reported from phase II study of tivantinib in colorectal cancer

Jan. 14, 2013

Initial results available from phase I/II study of indibulin in metastatic breast cancer

Jan. 14, 2013

Novartis prepares new protein kinase inhibitors

Jan. 14, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...